Aptevo Therapeutics Inc. (APVO)

Aptevo Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	8.71	16.9	22.64	45.04	39.98
Cash & Short-Term Investments	8.71	16.9	22.64	45.04	39.98
Cash Growth	-48.45%	-25.32%	-49.75%	12.67%	221.17%
Accounts Receivable	-	-	2.5	3.66	2.37
Receivables	-	-	2.5	3.66	2.37
Prepaid Expenses	1.69	1.47	1.57	1.82	2.23
Restricted Cash	-	-	-	1.26	2.56
Other Current Assets	0.26	0.69	0.74	0.78	0.13
Total Current Assets	10.66	19.07	27.45	52.57	47.26
Property, Plant & Equipment	4.93	5.78	6.77	3.96	5.54
Other Long-Term Assets	-	-	-	0.07	0.75
Total Assets	15.59	24.84	34.22	56.6	53.55
Accounts Payable	3.05	3.98	3.5	3.46	5.58
Accrued Expenses	1.86	2.1	2.11	2.08	2.76
Current Portion of Long-Term Debt	-	-	2	11.67	5
Current Portion of Leases	0.77	-	0.42	-	-
Current Unearned Revenue	-	-	-	15.47	-
Other Current Liabilities	0.53	1.14	0.68	2.09	1.2
Total Current Liabilities	6.21	7.22	8.71	34.76	14.54
Long-Term Debt	-	-	1.46	3.71	20.05
Long-Term Leases	4.63	5.4	6.08	1.34	2.36
Long-Term Unearned Revenue	-	-	-	15.58	-
Total Liabilities	10.84	12.62	16.24	55.39	36.95
Common Stock	0.08	0.06	0.05	0.05	0.05
Additional Paid-In Capital	252.25	235.61	223.96	215.23	202.15
Retained Earnings	-247.58	-223.45	-206.04	-214.06	-185.61
Shareholders' Equity	4.76	12.22	17.97	1.22	16.59
Total Liabilities & Equity	15.59	24.84	34.22	56.6	53.55
Total Debt	5.4	5.4	9.96	16.72	27.41
Net Cash (Debt)	3.32	11.51	12.68	28.33	12.57
Net Cash Growth	-71.18%	-9.24%	-55.24%	125.46%	-
Net Cash Per Share	12.01	-	-	-	-
Filing Date Shares Outstanding	1.46	0.01	-	-	-
Total Common Shares Outstanding	1.46	0.01	-	-	-
Working Capital	4.45	11.84	18.74	17.81	32.73
Book Value Per Share	3.26	1021.99	-	-	-
Tangible Book Value	4.76	12.22	17.97	1.22	16.59
Tangible Book Value Per Share	3.26	1021.99	-	-	-
Machinery	12.26	12.26	12.26	12.43	11.73
Leasehold Improvements	2.23	2.23	2.23	2.23	2.23

Updated Feb 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q